IP Library › Patent Application 63196793
Patent Application Provisional
App. No. 63/196,793 · Confirmation No. 9241

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

Applicant: AstraZeneca AB
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2023-05-04 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2023-05-04 APP.FILE.REC Filing Receipt 3 View
2023-05-02 R48.REQ Request under Rule 48 correcting inventorship 3 View
2023-05-02 N417.PYMT Electronic Fee Payment 2 View
2023-05-02 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-05-02 ADS Application Data Sheet 10 View
2021-06-14 APP.FILE.REC Filing Receipt 3 View
2021-06-04 ADS Application Data Sheet 9 View
2021-06-04 SPEC Specification 38 View
2021-06-04 CLM Claims 2 View
2021-06-04 ABST Abstract 1 View
2021-06-04 DRW Drawings-only black and white line drawings 9 View
2021-06-04 WFEE Fee Worksheet (SB06) 2 View
2021-06-04 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/196,793
Filed
2021-06-04